Programme Overview
The LAAClub series is comprised of 4 digital modules focusing on LEAN LAAC patient journey. Lean LAAC aims at maximizing the productivity and focuses on finding all eligible patients, procedure simplification, and enabling early discharge.
Educational objectives
In this module, our faculty will share their approaches to treating patients with non-valvular atrial fibrillation (NVAF) using ablation and left atrial appendage closure (LAAC) therapy. The discussion will cover a range of topics, from the findings of the OPTION Clinical Trial — which compares the WATCHMAN FLX device with oral anticoagulation in post-ablation patients — to strategies for stroke management in this new patient population and how the OPTION Trial outcomes may impact clinical practice.
Faculty:
Prof Eloi Marijon, European Hospital Georges Pompidou, Paris, FR
Prof Marek Grygier, Poznan University of Medical Sciences, Poznan, PL
Dr Melanie Gunawardene, Asklepios St. Georg Clinic, Hamburg , DE
Dr Francesco Tomassini, Ospedale di Rivoli, Rivoli, IT